Literature DB >> 24771902

Antibiotic Therapy for Premature Rupture of Membranes and Preterm Labor and Effect on Fetal Outcome.

B Seelbach-Goebel1.   

Abstract

In Germany almost 10 % of children are born before the end of 37th week of gestation. In at least one quarter of these cases, ascending infection of the vagina plays a causative role, particularly during the early weeks of gestation. If, in addition to the decidua, the amniotic membrane, amniotic fluid and the umbilical cord are also affected, infection not only triggers uterine contractions and premature rupture of membranes but also initiates a systemic inflammatory reaction on the part of the fetus, which can increase neonatal morbidity. Numerous studies and meta-analyses have found that antibiotic therapy prolongs pregnancy and reduces neonatal morbidity. No general benefit of antibiotic treatment was found for premature uterine contractions. But it is conceivable that a subgroup of pregnant women would benefit from antibiotic treatment. It is important to identify this subgroup of women and offer them targeted treatment. This overview summarizes the current body of evidence on antibiotic treatment for impending preterm birth and the effect on neonatal outcomes.

Entities:  

Keywords:  antibiosis for impending preterm birth; impending preterm birth; premature rupture of membranes; premature uterine contractions

Year:  2013        PMID: 24771902      PMCID: PMC3964356          DOI: 10.1055/s-0033-1360195

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  98 in total

1.  The effect of the publication of a major clinical trial in a high impact journal on clinical practise: the ORACLE Trial experience.

Authors:  Sara Kenyon; David J Taylor
Journal:  BJOG       Date:  2002-12       Impact factor: 6.531

Review 2.  The enigma of spontaneous preterm birth.

Authors:  Louis J Muglia; Michael Katz
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

Review 3.  Antibiotics for ureaplasma in the vagina in pregnancy.

Authors:  Camille H Raynes Greenow; Christine L Roberts; Jane C Bell; Brian Peat; Gwendolyn L Gilbert; Sharon Parker
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

4.  Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years.

Authors:  B H Yoon; R Romero; J S Park; C J Kim; S H Kim; J H Choi; T R Han
Journal:  Am J Obstet Gynecol       Date:  2000-03       Impact factor: 8.661

5.  Maternal infection-induced white matter injury is reduced by treatment with interleukin-10.

Authors:  Sheryl Rodts-Palenik; Josephine Wyatt-Ashmead; Yi Pang; Brad Thigpen; Zhengwei Cai; Phillip Rhodes; James N Martin; Joey Granger; William A Bennett
Journal:  Am J Obstet Gynecol       Date:  2004-10       Impact factor: 8.661

6.  Association of histologic chorioamnionitis, increased levels of cord blood cytokines, and intracerebral hemorrhage in preterm neonates.

Authors:  M K Tauscher; D Berg; M Brockmann; S Seidenspinner; C P Speer; P Groneck
Journal:  Biol Neonate       Date:  2003

7.  Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis.

Authors:  Matthew J Bizzarro; Louise-Marie Dembry; Robert S Baltimore; Patrick G Gallagher
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

8.  The importance of intra-amniotic inflammation in the subsequent development of atypical chronic lung disease.

Authors:  Joonho Lee; Kyung Joon Oh; Hye Jin Yang; Joong Shin Park; Roberto Romero; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2009-10

9.  Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks' gestation.

Authors:  C M Salafia; V K Minior; T S Rosenkrantz; J C Pezzullo; E J Popek; W Cusick; A M Vintzileos
Journal:  Am J Perinatol       Date:  1995-11       Impact factor: 1.862

10.  Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor.

Authors:  Jennifer H Steel; Sotiris Malatos; Nigel Kennea; A David Edwards; Lynda Miles; Philip Duggan; Peter R Reynolds; Robert G Feldman; Mark H F Sullivan
Journal:  Pediatr Res       Date:  2005-01-19       Impact factor: 3.756

View more
  6 in total

Review 1.  Metagenomics Approaches to Investigate the Neonatal Gut Microbiome.

Authors:  Zakia Boudar; Sofia Sehli; Sara El Janahi; Najib Al Idrissi; Salsabil Hamdi; Nouzha Dini; Hassan Brim; Saaïd Amzazi; Chakib Nejjari; Michele Lloyd-Puryear; Hassan Ghazal
Journal:  Front Pediatr       Date:  2022-06-21       Impact factor: 3.569

2.  Obstetrical disease spectrum in China: an epidemiological study of 111,767 cases in 2011.

Authors:  Xiao-Lin Luo; Wei-Yuan Zhang
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

3.  Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin.

Authors:  Richard G Brown; Julian R Marchesi; Yun S Lee; Ann Smith; Benjamin Lehne; Lindsay M Kindinger; Vasso Terzidou; Elaine Holmes; Jeremy K Nicholson; Phillip R Bennett; David A MacIntyre
Journal:  BMC Med       Date:  2018-01-24       Impact factor: 8.775

4.  Cytokine profiles of umbilical cord blood mononuclear cells upon in vitro stimulation with lipopolysaccharides of different vaginal gram-negative bacteria.

Authors:  Edith Reuschel; Martina Toelge; Kathrin Entleutner; Ludwig Deml; Birgit Seelbach-Goebel
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

Review 5.  Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies.

Authors:  Katherine M Nelson; N'Dea Irvin-Choy; Matthew K Hoffman; Jason P Gleghorn; Emily S Day
Journal:  Adv Drug Deliv Rev       Date:  2020-09-28       Impact factor: 15.470

Review 6.  Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.

Authors:  Lucy L Furfaro; Barbara J Chang; Matthew S Payne
Journal:  Front Microbiol       Date:  2018-01-11       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.